H&B: Overcoming trust barriers in menopause supplements


Speaking at the Biogredia Health & Nutrition Summit in Gstaad, Switzerland last week,ย Alex Glover, nutritional development lead at Holland & Barrett (H&B), drew attention to the fact that aย lot of women are uncomfortable discussing menopause and its symptoms, leading to misinformation and a lack of support.

“It is a massively underserved community, and many women will be in that post-menopausal transition for such a significant portion of their lives,” he said. “Our priority is to increase quality of life, which is why we put such a big focus on it as a business.โ€ย 

Until recently, the majority of medical research and literature centered predominantly on male physiology, which led to the diagnosis and treatment of females based on male-centered research, and while improvements have been made in this area, little research is conducted in women of menopausal age.ย 

“Itโ€™s quite shocking given its such a significant cohort,” Glover added, “But I’m expecting that as menopause is becoming a consumer-led area of interest, the science will hopefully follow, and I expect and hope to see a lot more research specific on menopause in the next 5 to 10 years.โ€”

Different needs at different agesย โ€‹

We cannot just consider women as a homogenous group when talking about womenโ€™s health, Glover noted, adding that age, ethnicity, disability, education and financial situation, all diversify the category, making it imperative to cater to the nuances of womenโ€™s needs.

While there are many crossover categories, age in particular delineates key concerns for women, with younger generations looking for support with periods, fertility issues, miscarriage, endometriosis, polycystic ovary syndrome (PCOS), primary ovarian insufficiency (POI), urinary tract infections (UTIs), ovarian cysts and uterine fibroids.ย 



Source link

>